Home » today » Health » Corona: Curevac struggles with vaccine costs ++ Hard verdict on proof of recovery

Corona: Curevac struggles with vaccine costs ++ Hard verdict on proof of recovery

Newsblog

Corona: Vaccine failed – Curevac is struggling with costs

news author-info_wrapper-image ">

Updated: 05/25/2022, 17:22

| Reading time: 8 minutes

video-opener video-opener--background " id="fwid1">
video video-kaltura">

Low effectiveness: Curevac not part of the German vaccination program


Low effectiveness: Curevac not part of the German vaccination program

With the development of its own vaccine against the corona virus, the Tübingen company Curevac raised high hopes. But now it is clear: The vaccine only has an effectiveness of 48 percent.

show description

Curevac continues to struggle with the cost of its failed Corona vaccine last year. More about this in the blog.


  • Omicron subvariant BA5. increases the number of cases in Portugal
  • Johnson takes responsibility for ‘Partygate’
  • Corona positive: Herbert Grönemeyer cancels his tour
  • An epidemiologist warns of more dangerous variants
  • Verdict: A false proof of recovery from corona justifies termination

Berlin. The corona pandemic in Germany continues to subside. On Wednesday, the Robert Koch Institute (RKI) reported a nationwide seven-day incidence of 281.8 per 100,000 inhabitants per week (previous day 307.2). The institute put the number of new infections at 49,141. Experts assume that the data does not reflect the actual course of infection.

In view of the situation, however, politicians and scientists do not want to give the all-clear during the pandemic. The Bremen epidemiologist Hajo Zeeb recently called for good preparation for possible new corona variants in autumn. A combination of delta and omicron or a completely new variant could occur, Zeeb said in an interview with the Evangelisches Pressedienst (epd).

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.